Establishment and histopathological study of patient-derived xenograft models and primary cell lines of epithelioid malignant peritoneal mesothelioma-Reference-Cited by-同舟云学术

Establishment and histopathological study of patient-derived xenograft models and primary cell lines of epithelioid malignant peritoneal mesothelioma

Published:2021 Issue:2 Volume:70 Page:225-235
ISSN:1341-1357
Container-title:Experimental Animals
language:en
Short-container-title:Exp. Anim.

Author:

Yang Zhi-Ran¹,Chen Zhi-Gao²,Ji Zhong-He¹,Lin Yu-Lin¹,Zhang Jue¹,Ma Ru¹,Li Zhao³,Jiang Xi³,Chen Qian²,Du Xue-Mei³,Li Yan¹³

Affiliation:

1. Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, No. 10 Tieyi Road, Yangfangdian Street, Haidian District, Beijing 100038, China

2. Thorgene Co., Ltd., Yizhuang Biomedical Park, Daxing District, Beijing, Beijing, China

3. Department of Pathology, Beijing Shijitan Hospital, Capital Medical University, Capital Medical University, No. 10 Tieyi Road, Yangfangdian Street, Haidian District, Beijing, China

Publisher

Japanese Association for Laboratory Animal Science

Subject

General Veterinary,General Biochemistry, Genetics and Molecular Biology,Animal Science and Zoology,General Medicine

Link

https://www.jstage.jst.go.jp/article/expanim/70/2/70_20-0119/_pdf

Reference24 articles.

1. 1. Price B. Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol. 1997; 145: 211–218.

2. 3. Feldman AL, Libutti SK, Pingpank JF, Bartlett DL, Beresnev TH, Mavroukakis SM, et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol. 2003; 21: 4560–4567.

3. 4. Sugarbaker PH, Yan TD, Stuart OA, Yoo D. Comprehensive management of diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol. 2006; 32: 686–691.

4. 5. Yano H, Moran BJ, Cecil TD, Murphy EM. Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma. Eur J Surg Oncol. 2009; 35: 980–985.

5. 6. Hompes D, D’Hoore A, Van Cutsem E, Fieuws S, Ceelen W, Peeters M, et al. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study. Ann Surg Oncol. 2012; 19: 2186–2194.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma;Molecular Cancer;2024-01-10

2. Efficacy and Adverse Events of Apatinib Salvage Treatment for Refractory Diffuse Malignant Peritoneal Mesothelioma: A Pilot Study;Frontiers in Oncology;2022-07-01

3. NPM2 in malignant peritoneal mesothelioma: from basic tumor biology to clinical medicine;World Journal of Surgical Oncology;2022-04-30